Sort
48,018 grants matching “immunotherapy”
NGTC - UCL
$1,100,987Martin Pule · University College London · OT2 · FY2024 · CA
LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens
$1,100,687Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2018 · AI
Immune function and the progression to type 1 diabetes
$1,100,265University Of Florida · P01 · FY2003 · AI
Adenosine Receptor Agonists as an Immunotherapy for Biodefense
$1,100,000Peter B Ernst · University Of Virginia · U01 · FY2006 · AI
Defining and Reconstructing the Human Ancestral Microbiome
$1,099,000Justin Sonnenburg · Stanford University · DP1 · FY2021 · AT
Defining and Reconstructing the Human Ancestral Microbiome
$1,099,000Justin Sonnenburg · Stanford University · DP1 · FY2017 · AT
Defining and Reconstructing the Human Ancestral Microbiome
$1,099,000Justin Sonnenburg · Stanford University · DP1 · FY2019 · AT
Defining and Reconstructing the Human Ancestral Microbiome
$1,099,000Justin Sonnenburg · Stanford University · DP1 · FY2020 · AT
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
$1,098,970Joel H Collier · Duke University · R01 · FY2025 · AI
CAP-IT Center for LNP RNA Immunoprevention
$1,098,880Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2023 · CA
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$1,098,673Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Deciphering CTCF code in human host and viral epigenomes
$1,098,673Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Novel Targets for Vaccine Therapy
$1,097,667Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Ann Arbor regional CCOP
$1,097,660Saint Joseph Mercy Health System · U10 · FY2005 · CA
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,095,066Duke University · P50 · FY2003 · NS
UNDERSTANDING THE ROLE OF CDK12 AND IDENTIFYING IMMUNOTHERAPY AND SYNTHETIC LETHAL TARGETING STRATEGIES
$1,095,000Regents Of The University Of California, San Francisco, The · · FY2020 · Department of the Army
Adenosine Receptor Agonists as an Immunotherapy for Biodefense
$1,094,420Peter B Ernst · University Of Virginia · U01 · FY2009 · AI
Depletion, Repopulation and Tolerance in Sensitized Recipients
$1,094,006Stuart Johnston Knechtle · Duke University · U19 · FY2021 · AI
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,093,892Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2010 · AI
STING agonist-expressing BCG for bladder cancer
$1,092,982Todd Wallach · Oncosting Llc · R44 · FY2023 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$1,092,801Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
SPORE in Head and Neck Cancer
$1,092,383Jennifer R Grandis · University Of Pittsburgh At Pittsburgh · P50 · FY2009 · CA
Rapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy
$1,091,666David L Lampi Hermanson · B-Mogen Biotechnologies, Inc. · R44 · FY2019 · CA
Stanford Project 2
$1,091,369Calvin J Kuo · University Of California, San Francisco · U54 · FY2017 · CA
SRC ON PRIMARY AND METASTATIC TUMORS OF THE CNS
$1,091,364Duke University · P50 · FY2002 · NS